Research Article
Microtransesophageal Echocardiographic Guidance during Percutaneous Interatrial Septal Closure without General Anaesthesia
Table 2
In-hospital follow-up data after percutaneous ASD and PFO closure using TEE and micro-TEE.
| | ASD | PFO | TEE | Micro-TEE | TEE | Micro-TEE |
| Number, n | 46 | 36 | 55 | 65 | Device diameter (mm) | 26 (10–40) | 27 (10–35) | 25 (23–35) | 27 (23–35) | Complications, n (%) | SVT | 0 (0%) | 1 (2.8%) | 0 (0%) | 2 (3.1%) | Device embolism | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | Bleeding no transfusion | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | Pericardial effusion | 1 (2.2%) | 0 (0%) | 1 (1.8%) | 0 (0%) | TTE, n | 46 (100%) | 36 (100%) | 55 (100%) | 65 (100%) | RLS, n (%) | No shunt | — | — | 20 (36.4%) | 53 (81.5%) | Minimal | — | — | 26 (47.3%) | 8 (12.3%) | Moderate | — | — | 4 (7.3%) | 2 (3.1%) | Severe | — | — | 5 (9.1%) | 2 (3.1%) | LRS, n (%) | 11 (24%) | 3 (8.3%) | — | — |
|
|
Data are presented as median (range); ASD, atrial septal defect; PFO, patent foramen ovale; TEE, transesophageal echocardiography; SVT, supraventricular tachycardia; TTE, transthoracic echocardiography; RLS, right-to-left shunt; LRS, left-to-right shunt. |